Search research articles
Contact Us
Filters
Showing results (81-90 of 162) with videos related to
Page
of 17
Sort By:
Oncotarget
|
March 9, 2019
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas
Camelia Quek, Robert V Rawson, Peter M Ferguson, et al.
Pathology
|
March 30, 2016
Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making
Ricardo De Paoli-Iseppi, Peter A Johansson, Alexander M Menzies, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 20, 2026
GLUT1 expression, lymphocyte distribution and CD3<sup>+</sup> T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma
Elizabeth C Paver, Tuba N Gide, Zarwa Yaseen, et al.
Neuro-Oncology
|
June 28, 2014
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
Diego M Marzese, Richard A Scolyer, Maria Roqué, et al.
Journal of the American Academy of Dermatology
|
December 12, 2022
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes
Mary-Ann El Sharouni, Robert V Rawson, Alison J Potter, et al.
Oncotarget
|
June 19, 2015
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
Anja Heinemann, Carleen Cullinane, Ricardo De Paoli-Iseppi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials
Jarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Frontiers in Immunology
|
August 25, 2022
Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome
Grace H Attrill, Hansol Lee, Annie T Tasker, et al.
Cancers
|
July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
Tuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
The Journal of Pathology. Clinical Research
|
April 19, 2020
Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value
Raymond Barnhill, Pieter-Jan van Dam, Peter Vermeulen, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 162) with videos related to
Sort By:
Page
of 17
Oncotarget
|
March 9, 2019
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas
Camelia Quek, Robert V Rawson, Peter M Ferguson, et al.
Pathology
|
March 30, 2016
Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making
Ricardo De Paoli-Iseppi, Peter A Johansson, Alexander M Menzies, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 20, 2026
GLUT1 expression, lymphocyte distribution and CD3<sup>+</sup> T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma
Elizabeth C Paver, Tuba N Gide, Zarwa Yaseen, et al.
Neuro-Oncology
|
June 28, 2014
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
Diego M Marzese, Richard A Scolyer, Maria Roqué, et al.
Journal of the American Academy of Dermatology
|
December 12, 2022
Melanomas in children and adolescents: Clinicopathologic features and survival outcomes
Mary-Ann El Sharouni, Robert V Rawson, Alison J Potter, et al.
Oncotarget
|
June 19, 2015
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
Anja Heinemann, Carleen Cullinane, Ricardo De Paoli-Iseppi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2019
Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials
Jarem Edwards, Annie Tasker, Inês Pires da Silva, et al.
Frontiers in Immunology
|
August 25, 2022
Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome
Grace H Attrill, Hansol Lee, Annie T Tasker, et al.
Cancers
|
July 2, 2021
Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
Tuba N Gide, Inês Pires da Silva, Camelia Quek, et al.
The Journal of Pathology. Clinical Research
|
April 19, 2020
Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value
Raymond Barnhill, Pieter-Jan van Dam, Peter Vermeulen, et al.
Page
of 17